Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Nano Letters|September 14, 2006
Manganese-induced growth of GaAs nanowiresFaustino Martelli, Silvia Rubini, Matteo Piccin, et al.Journal of Experimental & Clinical Cancer Research : CR|May 2, 2025
Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanomaFrancesco Noto, Jacopo Mancini, Adriana Rosa Gambardella, et al.Scientific Reports|October 8, 2017
Organs on chip approach: a tool to evaluate cancer -immune cells interactionsElena Biselli, Elena Agliari, Adriano Barra, et al.Cancers|November 14, 2019
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell KillingSara Andreone, Francesca Spadaro, Carla Buccione, et al.Lab on a Chip|July 24, 2020
Organ-on-chip model shows that ATP release through connexin hemichannels drives spontaneous Ca2+ signaling in non-sensory cells of the greater epithelial ridge in the developing cochleaFlavia Mazzarda, Annunziata D'Elia, Roberto Massari, et al.Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.Scientific Reports|April 26, 2017
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cellsStefania Parlato, Adele De Ninno, Rosa Molfetta, et al.Journal of Experimental & Clinical Cancer Research : CR|July 26, 2024
IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cellsAdriana Rosa Gambardella, Caterina Antonucci, Cristiana Zanetti, et al.Journal of Experimental & Clinical Cancer Research : CR|November 18, 2022
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastomaValeria Lucarini, Ombretta Melaiu, Silvia D'Amico, et al.The Journal of Investigative Dermatology|September 14, 2016
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against MelanomaValeria Lucarini, Carla Buccione, Giovanna Ziccheddu, et al.Pageof 5